The use of buprenorphine/naloxone to treat borderline personality disorder: a case report
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-6673
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The use of buprenorphine/naloxone to treat borderline personality disorder: a case report ; volume:9 ; number:1 ; day:15 ; month:3 ; year:2022 ; pages:1-3 ; date:12.2022
Borderline Personality Disorder and Emotion Dysregulation ; 9, Heft 1 (15.3.2022), 1-3, 12.2022
- Urheber
-
Hansen, Brenna
Inch, Katelyn M.
Kaschor, Brenna A.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40479-022-00181-1
- URN
-
urn:nbn:de:101:1-2022052918574391582688
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:29 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hansen, Brenna
- Inch, Katelyn M.
- Kaschor, Brenna A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone
A retrospective evaluation of patients switched from buprenorphine (subutex) to the buprenorphine/naloxone combination (suboxone)
Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone®) in Spain
Healthcare provider perspectives on emergency department-initiated buprenorphine/naloxone: a qualitative study
Buprenorphine/naloxone – one formulation that doesn’t fit all: a case report
Perioperative opioid requirements of patients receiving sublingual buprenorphine-naloxone: a case series
Case report: Successful induction of buprenorphine/naloxone using a microdosing schedule and assertive outreach
Naloxone should remain the appropriate antidote to treat opioid overdose
Safety and effectiveness of Buprenorphine-Naloxone sublingual tablet in the treatment of opioid use disorder
Study design to evaluate a group-based therapy for support persons of adults on buprenorphine/naloxone
Short imagery rescripting Intervention to treat emotionally dysregulated behavior in borderline personality disorder: an exploratory study
Dissociation, trauma, and borderline personality disorder
Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone
A retrospective evaluation of patients switched from buprenorphine (subutex) to the buprenorphine/naloxone combination (suboxone)
Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone®) in Spain
Healthcare provider perspectives on emergency department-initiated buprenorphine/naloxone: a qualitative study
Buprenorphine/naloxone – one formulation that doesn’t fit all: a case report
Perioperative opioid requirements of patients receiving sublingual buprenorphine-naloxone: a case series
Case report: Successful induction of buprenorphine/naloxone using a microdosing schedule and assertive outreach
Naloxone should remain the appropriate antidote to treat opioid overdose
Safety and effectiveness of Buprenorphine-Naloxone sublingual tablet in the treatment of opioid use disorder
Study design to evaluate a group-based therapy for support persons of adults on buprenorphine/naloxone
Short imagery rescripting Intervention to treat emotionally dysregulated behavior in borderline personality disorder: an exploratory study
Dissociation, trauma, and borderline personality disorder
Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone
A retrospective evaluation of patients switched from buprenorphine (subutex) to the buprenorphine/naloxone combination (suboxone)
Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone®) in Spain
Healthcare provider perspectives on emergency department-initiated buprenorphine/naloxone: a qualitative study
Buprenorphine/naloxone – one formulation that doesn’t fit all: a case report
Perioperative opioid requirements of patients receiving sublingual buprenorphine-naloxone: a case series
Case report: Successful induction of buprenorphine/naloxone using a microdosing schedule and assertive outreach
Naloxone should remain the appropriate antidote to treat opioid overdose
Safety and effectiveness of Buprenorphine-Naloxone sublingual tablet in the treatment of opioid use disorder
Study design to evaluate a group-based therapy for support persons of adults on buprenorphine/naloxone
Short imagery rescripting Intervention to treat emotionally dysregulated behavior in borderline personality disorder: an exploratory study